← Back to Search

Other

Topical Powder for Rosacea

Phase 2
Waitlist Available
Research Sponsored by Dermata Therapeutics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

Study Summary

This trial is testing a new powder medication for people with moderate to severe acne rosacea. They want to see if it is safe and effective.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Efficacy as measured by Investigator Global Assessment (IGA)
Efficacy as measured by lesion counts
Secondary outcome measures
Incidence of adverse events as a measure of safety and tolerability

Trial Design

2Treatment groups
Experimental Treatment
Group I: Study Treatment 2Experimental Treatment1 Intervention
Placebo powder mixed with Hydrogen Peroxide
Group II: Study Treatment 1Experimental Treatment1 Intervention
DMT310 Powder mixed with Hydrogen Peroxide

Find a Location

Who is running the clinical trial?

Dermata TherapeuticsLead Sponsor
5 Previous Clinical Trials
983 Total Patients Enrolled
1 Trials studying Rosacea
107 Patients Enrolled for Rosacea

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Texas
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Met criteria
~53 spots leftby Apr 2025